IRS1 and gastric cancer: We found that GC cell lines show differential sensitivity to IGF1R targeted inhibitor, and the IGF1/IRS1/IGF1R axis is highly activated in part of GC patients, indicating a stratified approach based on the IGF1/IGF1R activity.